Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABBOTT LABORATORIES | 5,000 | 200,000 | +195,000 | 1 | 18 | 6.89% | +18 |
| JAZZ PHARMACEUTICALS PLC(JAZZ) | 167,816 | 167,816 | 0 | 32 | 40 | 15.36% | +9 |
| ENANTA PHARMACEUTICALS INC(ENTA) | 2,866,138 | 2,866,138 | 0 | 36 | 42 | 15.88% | +6 |
| ULTRAGENYX PHARMACEUTICAL IN(RARE) | 390,879 | 390,879 | 0 | 8 | 13 | 4.96% | +5 |
| EXELIXIS INC(EXEL) | 415,693 | 370,693 | -45,000 | 18 | 20 | 7.66% | +2 |
| BIOGEN INC(BIIB) | 20,000 | 20,000 | 0 | 4 | 4 | 1.64% | +1 |
| REGENERON PHARMACEUTICALS(REGN) | 4,000 | 6,000 | +2,000 | 3 | 4 | 1.42% | +1 |
| EVOLUS INC(EOLS) | 157,985 | 157,985 | 0 | 1 | 1 | 0.42% | 0 |
| BIOMARIN PHARMACEUTICAL INC(BMRN) | 524,786 | 524,786 | 0 | 30 | 30 | 11.41% | 0 |
| BIONTECH SE-ADR(BNTX) | 59,523 | 59,523 | 0 | 5 | 6 | 2.10% | 0 |
| INMODE LTD(INMD) | 120,942 | 120,942 | 0 | 2 | 2 | 0.67% | 0 |
| GSK PLC-SPON ADR(GSK) | 96,729 | 96,729 | 0 | 5 | 5 | 1.93% | -0 |
| ARDELYX INC | 500,000 | 534,523 | +34,523 | 3 | 3 | 1.04% | -0 |
| VANDA PHARMACEUTICALS INC(VNDA) | 1,180,388 | 1,180,388 | 0 | 8 | 7 | 2.74% | -1 |
| SUPERNUS PHARMACEUTICALS INC(SUPN) | 280,681 | 280,681 | 0 | 15 | 13 | 4.96% | -1 |
| SANOFI-ADR(SNY) | 323,946 | 323,946 | 0 | 16 | 14 | 5.25% | -2 |
| EMBECTA CORP(EMBC) | 735,340 | 1,135,340 | +400,000 | 7 | 4 | 1.41% | -3 |
| ALKERMES PLC(ALKS) | 107,822 | 0 | -107,822 | 4 | 0 | — | -4 |
| INDIVIOR PHARMACEUTICALS INC(INDV) | 339,532 | 0 | -339,532 | 10 | 0 | — | -10 |
| UNITED THERAPEUTICS CORP(UTHR) | 84,282 | 69,282 | -15,000 | 50 | 38 | 14.26% | -12 |